NME2-driven epigenetic control of inflammasome-activated microglial lineage dynamics promotes sepsis-associated encephalopathy

Key Points

• Sepsis-associated encephalopathy involves changes in microglial lineage dynamics, driven by nme2.
• Key evidence shows that targeting nme2 may mitigate symptoms of encephalopathy and promote recovery.
• Analysis focused on the inflammasome's role in microglial activation and lineage changes during sepsis.
• Findings highlight the potential for new treatments aimed at the epigenetic mechanisms underlying encephalopathy.